Episode Details

The Supreme Court has ruled in favor of the governments right to negotiate drug prices, a significant shift in how high-priced medications are handled for seniors. The Inflation Reduction Act of 2022 allows the government to haggle with drug manufacturers over the cost of certain medications, with the first price cuts set to begin in 2026. The administration has identified twenty-five prescription drugs for negotiation, including popular ones like Ozempic and Wegovy. The pharmaceutical industry has opposed this move, arguing that insurers and pharmacy benefit managers are the real drivers of high drug costs. However, without court intervention, Congress would need to act to stop this negotiation program. The administration is moving forward, and the next batch of drugs targeted for negotiation has already been announced.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/3284fdf9d907ef0d